These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Progressive glomerular toxicity of ifosfamide in children. Prasad VK, Lewis IJ, Aparicio SR, Heney D, Hale JP, Bailey CC, Kinsey SE. Med Pediatr Oncol; 1996 Sep; 27(3):149-55. PubMed ID: 8699991 [Abstract] [Full Text] [Related]
6. Long-term evaluation of Ifosfamide-related nephrotoxicity in children. Oberlin O, Fawaz O, Rey A, Niaudet P, Ridola V, Orbach D, Bergeron C, Defachelles AS, Gentet JC, Schmitt C, Rubie H, Munzer M, Plantaz D, Deville A, Minard V, Corradini N, Leverger G, de Vathaire F. J Clin Oncol; 2009 Nov 10; 27(32):5350-5. PubMed ID: 19826134 [Abstract] [Full Text] [Related]
7. Renal dysfunctions secondary to ifosfamide treatment in children. Tokuc G, Yalçiner A, Kebudi R, Dogan S, Görgün O, Ayan I. J Exp Clin Cancer Res; 1997 Jun 10; 16(2):227-30. PubMed ID: 9261752 [Abstract] [Full Text] [Related]
8. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide. Hartmann JT, Fels LM, Franzke A, Knop S, Renn M, Maess B, Panagiotou P, Lampe H, Kanz L, Stolte H, Bokemeyer C. Anticancer Res; 2000 Jun 10; 20(5C):3767-73. PubMed ID: 11268452 [Abstract] [Full Text] [Related]
13. Renal toxicity of ifosfamide in pilot regimens of the intergroup rhabdomyosarcoma study for patients with gross residual tumor. Raney B, Ensign LG, Foreman J, Khan F, Newton W, Ortega J, Ragab A, Wharam M, Wiener E, Maurer H. Am J Pediatr Hematol Oncol; 1994 Nov 10; 16(4):286-95. PubMed ID: 7978043 [Abstract] [Full Text] [Related]
15. [A prospective study on nephrotoxicity induced by continuous infusion of high-dose ifosfamide (15/m2)]. Ferrari S, Zolezzi C, Bacci G, Pieretti F, Iantorno D, Figus E, Pizzoferrato A. Minerva Pediatr; 1997 Jul 10; 49(1-2):29-37. PubMed ID: 9132558 [Abstract] [Full Text] [Related]
16. Renal impairment and hypertension in brain tumor patients treated in childhood are mainly associated with cisplatin treatment. Pietilä S, Ala-Houhala M, Lenko HL, Harmoinen AP, Turjanmaa V, Mäkipernaa A. Pediatr Blood Cancer; 2005 Apr 10; 44(4):363-9. PubMed ID: 15586356 [Abstract] [Full Text] [Related]
17. Long-term follow-up of renal function after high-dose methotrexate treatment in children. Grönroos MH, Jahnukainen T, Möttönen M, Perkkiö M, Irjala K, Salmi TT. Pediatr Blood Cancer; 2008 Oct 10; 51(4):535-9. PubMed ID: 18523995 [Abstract] [Full Text] [Related]
18. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system. Stöhr W, Paulides M, Bielack S, Jürgens H, Koscielniak E, Rossi R, Langer T, Beck JD. Pediatr Blood Cancer; 2007 Feb 10; 48(2):140-7. PubMed ID: 16724313 [Abstract] [Full Text] [Related]
19. Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Patzer L, Ringelmann F, Kentouche K, Fuchs D, Zintl F, Brandis M, Zimmerhackl LB, Misselwitz J. Bone Marrow Transplant; 2001 Feb 10; 27(3):319-27. PubMed ID: 11277181 [Abstract] [Full Text] [Related]